Nuttapong Ngamphaiboon

22PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMolecular targetsModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 09, 2026
Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicentre propensity-matched study.

|Feb 03, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122.

Anthony T C Chan, Victor Ho Fun Lee, Ruey-Long Hong

|Mar 07, 2025
Postoperative Radiation With or Without Concurrent Chemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma With Multiple Intermediate Risks: A Propensity Score-Matched Study.

Thun Leewiboonsilp, Chuleepon Jianpinijnan, Nintita Sripaiboonkij Thokanit

|Jan 08, 2025
Changing Landscape of Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma Treatment and Survival Trends in Thailand: A 13-Year Multicenter Retrospective Study of Patients.

Nuttapong Ngamphaiboon, Arunee Dechaphunkul, Chanida Vinayanuwattikun

|Oct 17, 2024
Predictive MINT Pathologic Risk Score for Adjuvant Chemotherapy in Resected Cholangiocarcinoma: A Propensity Score-Matched Multicenter Study in Thailand.

Jitlada Juengsamarn, Chatsuda Sookthon, Kaewta Jeerapradit

|Mar 08, 2024
Early recurrence, time-to-recurrence, and recurrence patterns: Assessing their impact on survival outcomes in head and neck squamous cell carcinoma (R/M-HNSCC) patients treated with first line platinum-based chemotherapy.

Pasvich Pitakpaiboonkul, Chuleeporn Jiarpinitnun, Poompis Pattaranutaporn

Pageof 4

Frequent Collaborators

2 joint publications

Barbara Burtness

2 joint publications

Richard Greil

2 joint publications

Denis Soulières

2 joint publications

Makoto Tahara